JACC: Cardiovascular Imaging and JACC: Cardiova...
ST. LOUIS, Missouri, April 16 /PRNewswire/ -- Elsevier and the American
College of Cardiology announced today that
JACC: Cardiovascular Imaging (http://www.elsevier.com/locate/jacima) (ISSN:
1936-878X) and JACC: Cardiovascular Interventions
(http://www.elsevier.com/locate/JACINT) (ISSN: 1936-8798) have been selected
for coverage in MEDLINE. Maintained by the U.S. National Library of
Medicine(R), MEDLINE (Medical Literature Analysis and Retrieval System
Online) is a premier bibliographic database containing approximately 13
million references to journal articles in life sciences.
JACC: Cardiovascular Imaging editor-in-chief, Dr Jagat Narula commented:
"We are delighted that the Journal has been accepted for inclusion in
MEDLINE
so soon after its launch in 2008. Inclusion in MEDLINE speaks not only to the
quality of the Journal's editorial content, but to the growing importance of
an integrated approach to cardiovascular imaging."
Dr. Spencer King, editor-in-chief of JACC: Cardiovascular Interventions
agrees. "Acceptance by MEDLINE is a strong endorsement for the importance of
these new titles. We are committed to providing the most clinically-relevant
and timely information in the field of interventional cardiology."
JACC: Cardiovascular Imaging and JACC: Cardiovascular Interventions are
published monthly in both print and online formats. In addition to original
research, editorials, perspectives, and other content, both journals provide
expanded online features such as, moving clinical images, video interviews,
online discussion groups and more.
About Elsevier
Elsevier is a world-leading publisher of scientific, technical and
medical information products and services. Working in partnership with the
global science and health communities, Elsevier's 7,000 employees in over 70
offices worldwide publish more than 2,000 journals and 1,900 new books per
year, in addition to offering a suite of innovative electronic products, such
as ScienceDirect (http://www.sciencedirect.com/), MD Consult
(http://www.mdconsult.com/), Scopus (http://www.info.scopus.com/),
bibliographic databases, and online reference works.
Elsevier (http://www.elsevier.com/) is a global business headquartered in
Amsterdam, The Netherlands and has offices worldwide. Elsevier is part of
Reed Elsevier Group plc (http://www.reedelsevier.com/), a world-leading
publisher and information provider. Operating in the science and medical,
legal, education and business-to-business sectors, Reed Elsevier provides
high-quality and flexible information solutions to users, with increasing
emphasis on the Internet as a means of delivery. Reed Elsevier's ticker
symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and
ENL (New York Stock Exchange).
About the American College of Cardiology
The American College of Cardiology is leading the way to optimal
cardiovascular care and disease prevention. The College is a 37,000-member
nonprofit medical society and bestows the credential Fellow of the American
College of Cardiology upon physicians who meet its stringent qualifications.
The College is a leader in the formulation of health policy, standards and
guidelines, and is a staunch supporter of cardiovascular research. The ACC
provides professional education and operates national registries for the
measurement and improvement of quality care. More information about the
association is available online at http://www.acc.org.
Name: Cynthia Baudendistel
Phone: +1-314-579-3344
E-mail: c.baudendistel@elsevier.com
AI Summary Disclaimer BETA
The content you are viewing has been generated or assisted by artificial
intelligence (AI). While efforts are made to ensure accuracy and clarity, AI-generated text may
contain inaccuracies, outdated information, or subjective interpretations. This content is intended
for general informational purposes only and should not be considered professional advice or factual
confirmation.
We encourage you to independently verify any information provided,
especially if it will be relied upon for making decisions or taking action. Any reliance you place
on this material is strictly at your own risk. The AI system that produced this content cannot
assess the specifics of individual circumstances, and results may vary based on context and
individual needs.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.
Create an Account
Create your FREE account to receive personalised announcements, watchlists, market updates, investment insights and new features.
Personalise your experience
Tell us a little about yourself to receive personalised content, announcements and relevant investment opportunities.